Pancreatic cancer: Diagnosis and endoscopic staging

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 4, 2010, Pages 375-385

  Galasso, D ^a   Carnuccio, A ^a   Larghi, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Endoscopic ultrasound; Pancreatic cancer; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUOROURACIL; GEMCITABINE; NARCOTIC ANALGESIC AGENT; ONYX 015; SHU 508; SONOVUE; TUMOR NECROSIS FACTOR ALPHA;

ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GENE THERAPY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DUODENUM PERFORATION; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; GENETIC RISK; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLYTIC VIROTHERAPY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS;

HUMANS; MASS SCREENING; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 77953167769     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. JEMAL A, SIEGEL R, WARD E, MURRAY T, XU J, THUN MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. PARKIN DM, BRAY F, FERLAY J, PISANI P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
3. ARIYAMA J, SUYAMA M, SATOH K, SAI J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998; 16: 396-401. (Pubitemid 28158047)
4. BEGER HG, RAU B, GANSAUGE R POCH B, LINK KH. Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003; 27: 1075-1084. (Pubitemid 37259985)
5. AHMAD NA, LEWIS JD, GINSBERG GG, HALLER DG, MORRIS JB, WILLIAMS NN, ROSATO EF, KOCHMAN ML. Long term survival after pancreatic resection for pancreatic adenocarcinomas. Am J Gastroenterol 2001; 96: 2609-2615. (Pubitemid 32889193)
6. HOWARD TJ, KRUG JE, YU J, ZYROMSKI NJ, SCHMIDT CM, JACOBSON LE, MADURA JA, WIEBKE EA, LILLEMOE KD. A margin-negative RO resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006; 10: 1338-1345.
7. VILMANN P, JACOBSEN GK, HENRIKSEN FW, HANCKE S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992; 38: 172-173.
8. VARADARAJULU S, ELOUBEIDI MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Gastrointest Endosc Clin N Am 2005; 15: 497-511.
9. CHANG KJ. EUS-guided fine needle injection (FNI) and anti-tumor therapy. Endoscopy 2006; 38(Suppl 1): S88-93.
10. LYNCH HT. Genetics and pancreatic cancer. Arch Surg 1994; 129: 266-268.
11. KLEIN AP, HRUBAN RH, BRUNE KA, PETERSEN GM, GOGGINS M. Familial pancreatic cancer. Cancer J 2001; 7: 266-273.
12. CHARI ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol 2007; 34: 284-294.
13. GREER JB, WHITCOMB DC, BRAND RE. Genetic predisposition to pancreatic cancer: a brief review. Am J Gastroenterol 2007; 102: 2564-2569.
14. LOWENFELS AB, MAISONNEUVE P, WHITCOMB DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am 2000; 84: 565-573. (Pubitemid 30346152)
15. LYNCH HT, BRAND RE, DETERS CA, SHAW TG, LYNCH JF. Hereditary pancreatic cancer. Pancreatology 2001; 1: 466-471.
16. BRAND RE, LERCH MM, RUBINSTEIN WS, NEOPTOLEMOS JP, WHITCOMB DC, HRUBAN RH, BRENTNALL TA, LYNCH HT, CANTO MI; PARTICIPANTS OF THE FOURTH INTERNATIONAL SYMPOSIUM OF INHERITED DISEASES OF THE PANCREAS. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469.
17. CANTO MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol 2007; 34: 295-302. (Pubitemid 47176623)
18. LARGHI A, VERNA EC, LECCA PG, COSTAMAGNA G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009; 15: 1907-1914.
19. KIMMEY MB, BRONNER MP, BYRD DR, BRENTNALL TA. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 2002; 56: S82-86.
20. CANTO MI, GOGGINS M, YEO CJ, GRIFFIN C, AXILBUND JE, BRUNE K, ALI SZ, JAGANNATH S, PETERSEN GM, FlSHMAN EK, PlANTADOSI S, GlARDIELLO FM, HRUBAN RH. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004; 2: 606-621.
21. CANTO MI, GOGGINS M, HRUBAN RH, PETERSEN GM, GlARDIELLO FM, YEO C, FISHMAN EK, BRUNE K, AXILBUND J, GRIFFIN C, ALI S, RICHMAN J, JAGANNATH S, KANTSEVOY SV, KALLOO AN. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006; 4: 766-781.
22. POLEY JW, KLUUT I, GOUMA DJ, HARINCK F, WAGNER A, AALFS C, VAN EUCK CH, CATS A KUIPERS EJ, NIO Y, FOCKENS P, BRUNO MJ. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009 2009; 104: 2175-2181.
23. LANGER P, KANN PH, FENDRICH V, HABBE N, SCHNEIDER M, SINA M, SLATER EP, HEVERHAGEN JT, GRESS TM, ROTHMUND M, BARTSCH DK. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 2009; 58: 1410-1418.
24. EVANS JP, BURKE W, CHEN R, BENNETT RL, SCHMIDT RA, DELLINGER EP, KIMMEY M, CRISPIN D, BRENTNALL TA, BYRD DR. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 1995; 32: 330-335.
25. BRENTNALL TA, BRONNER MP, BYRD DR, HAGGITT RC, KIMMEY MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247-255. (Pubitemid 29383653)
26. RULYAK SJ, KIMMEY MB, VEENSTRA DL, BRENTNALL TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003; 57: 23-29. (Pubitemid 36236794)
27. RUBENSTEIN JH, SCHEIMAN JM, ANDERSON MA. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 2007; 7: 514-525.
28. FARIA SC, TAMM EP, LOYER EM, SZKLARUK J, CHOI H, CHARNSANGAVEJ C. Diagnosis and staging of pancreatic tumors. Semin Roentgenol 2004; 39: 397-411.
29. FRANCIS IR. Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI). Cancer Imaging 2007; 7: S160-S165.
30. TOPAZIAN M, ENDERS F, KIMMEY M, BRAND R, CHAK A, CLAIN J, CUNNINGHAM J, ELOUBEIDI M, GERDES H, GRESS F, JAGANNATH S, KANTSEVOY S, LEBLANC JK, LEVY M, LIGHTDALE C, ROMAGNUOLO J, SALTZMAN JR, SAVlDES T, WIERSEMA M, WOODWARD T, PETERSEN G, CANTO M. Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc 2007; 66: 62-67.
31. DEUTSCH JC. EUS screening of subjects at risk for familial pancreatic cancer: what to do and what to expect. Gastrointest Endosc 2007; 66: 68-69.
32. DEWITT J, DEVEREAUX B, CHRISWELL M, MCGREEVY K, HOWARD T, IMPERIALE TF, CIACCIA D, LANE KA, MAGLINTE D, KOPECKY K, LEBLANC J, MCHENRY L, MADURA J, AISEN A, CRAMER H, CUMMINGS O, SHERMAN S. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer Ann Intern Med 2004; 141: 753-763.
33. KOCHMAN ML. EUS in pancreatic cancer. Gastrointest Endosc 2002; 56(4 Suppl): S6-S12.
34. KATZ MH, SAVIDES TJ, MOOSSA AR, BOUVET M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology 2005; 5: 576-590.
35. CATANZARO A, RICHARDSON S, VELOSO H, ISENBERG GA, WONG RC, SIVAK MV JR, CHAK A. Long-term follow-up of patients with clinically indeterminate suspicion of pancreatic cancer and normal EUS. Gastrointest Endosc 2003; 58: 836-840.
36. KLAPMAN JB, CHANG KJ, LEE JG, NGUYEN P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol 2005; 100: 2658-2661. (Pubitemid 43919631)
37. BHUTANI MS, GRESS FG, GIOVANNINI M, ERICKSON RA, CATALANO MF, CHAK A, DEPREZ PH, FAIGEL DO, NGUYEN CC. The No Endosonographic Detection of Tumor (NEST) Study: a case series of pancreatic cancers missed on endoscopic ultrasonography Endoscopy 2004; 36: 385-389.
38. ELOUBEIDI MA, VARADARAJULU S, DESAI S, WILCOX CM. Value of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. J Gastroenterol Hepatol 2008; 23: 567-570.
39. HO S, BONASERA RJ, POLLACK BJ, GRENDELL J, FEUERMAN M, GRESS F. A single-center experience of endoscopic ultrasonography for enlarged pancreas on computed tomography. Clin Gastroenterol Hepatol 2006; 4: 98-103.
40. HORWHAT JD, GERKE H, ACOSTA RD, PAVEY DA JOWELL PS. Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. JOP 2009; 10: 37-42.
41. SINGH S, REDDYMASU S, WAHEED S, VAIL M, HE J, TALAPANENI J, OLYAEE M. Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography: a single-center experience. Dig Dis Sci 2008; 53: 2799-2804.
42. BOUJAOUDE J. Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma. World J Gastroenterol 2007; 13: 3662-3666. (Pubitemid 47202162)
43. PENMAN ID. State of the art: putting EUS-guided block/neurolysis into perspective. Gastrointest Endosc 2009; 69(2 Suppl): S174-S175.
44. HAREWOOD GC, WIERSEMA MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002; 97: 1386-1391.
45. DEWITT J, MCGREEVY K, SHERMAN S, LEBLANC J. Utility of a repeated EUS at a tertiary-referral center. Gastrointest Endosc 2008; 67: 610-619.
46. ELOUBEIDI MA, TAMHANE A, VARADARAJULU S, WILCOX CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc 2006; 63: 622-629.
47. CHANG KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors. Endoscopy 2006; 38(Suppl 1): S56-S60.
48. KLAPMAN JB, LOGRONO R, DYE CE, WAXMAN I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003; 98: 1289-1294.
49. BINMOELLER KF, RATHOD VD. Difficult pancreatic mass FNA: tips for success. Gastrointest Endosc 2002; 56(Suppl): S86-S91.
50. MICHL P, PAULS S, GRESS TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20: 227-251.
51. HARTWIG W, SCHNEIDER L, DIENER MK, BERGMANN F, BÜCHLER MW, WERNER J. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg 2009; 96: 5-20.
52. MORTENSON MM, KATZ MH, TAMM EP, BHUTANI MS, WANG H, EVANS DB, FLEMING JB. Current diagnosis and management of unusual pancreatic tumors. Am J Surg 2008; 196: 100-113. (Pubitemid 351847784)
53. BRENNAN MF, KATTAN MW, KLIMSTRA D, CONLON K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004; 240: 293-298.
54. Sǎftoiu A, Vilmann P. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound 2009; 37: 1-17.
55. BECKER D, STROBEL D, BERNATIK T, HAHN EG. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001; 53: 784-789.
56. HOCKE M, SCHULZE E, GOTTSCHALK R TOPALIDIS T, DIETRICH CF. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006; 12: 246-250.
57. KITANO M, SAKAMOTO H, MATSUI U, ITO Y MAEKAWA K, VON SCHRENCK T, KUDO M. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2008; 67: 141-150.
58. GIOVANNINI M, HOOKEY LC, BORIES E, PESENTI C, MONGES G, DELPERO JR. Endoscopic ultrasound elastography: the first step towards virtual biopsy? Preliminary results in 49 patients. Endoscopy 2006; 38: 344-348.
59. JANSSEN J, SCHLÖRER E, GREINER L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc 2007; 65: 971-978.
60. HIRCHE TO, IGNEE A, BARREIROS AP, SCHREIBER-DIETRICH D, JUNGBLUT S, OTT M, HIRCHE H, DIETRICH CF. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 2008; 40: 910-917.
61. SǍFTOIU A, VILMANN P, GORUNESCU F, GHEONEA DI, GORUNESCU M, CIUREA T, POPESCU GL, IORDACHE A, HASSAN H, IORDACHE S. Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer Gastrointest Endosc 2008; 68: 1086-1094.
62. KHALID A, NODIT L, ZAHID M, BAUER K, BRODY D, FINKELSTEIN SD, MCGRATH KM. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006; 101: 2493-2500.
63. DAS A, NGUYEN CC, LI F, LI B. Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue Gastrointest Endosc 2008; 67: 861-867.
64. PENMAN ID, GILBERT D. Basic technique for celiac plexus block/neurolysis. Gastrointest Endosc 2009; 69(2 Suppl): S163-S165.
65. GERKE H, SILVA RG JR, SHAMOUN D, JOHNSON CJ, JENSEN CS. EUS characteristics of celiac ganglia with cytologic and histologic confirmation. Gastrointest Endosc 2006; 64: 35-39.
66. LEVY M, RAJAN E, KEENEY G, FLETCHER JG, TOPAZIAN M. Neural ganglia visualized by endoscopic ultrasound. Am J Gastroenterol 2006; 101: 1787-1791.
67. LEVY MJ, TOPAZIAN MD, WIERSEMA MJ, GAIN JE, RAJAN E, WANG KK, DE LA MORA JG, GLEESON FC, PEARSON RK, PELAEZ MC, PETERSEN BT, VEGE SS, CHARI ST. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am J Gastroenterol 2008; 103: 98-103.
68. WIERSEMA MJ, WIERSEMA LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 1996; 44: 656-662.
69. GUNARATNAM NT, SARMA AV, NORTON ID, WIERSEMA MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001; 54: 316-324. (Pubitemid 33665510)
70. TRAN QN, URAYAMA S, MEYERS FJ. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J Support Oncol 2006; 4: 460-462
71. PULI SR, REDDY JB, BECHTOLD ML, ANTILLON MR, BRUGGE WR. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: A meta-analysis and systematic review. Dig Dis Sci 2009; 54: 2330-2337.
72. SAHAI AV, LEMEUN V, LAM E, PAOUIN SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol 2009; 104: 326-329.
73. WYSE JM, CARONE M, USATII M, PASQUIN SC, SAHAI A. Results of the first randomized, duole blind, sham-controlled trial of EUS-guided celiac plexus neurolysis (EUS-CPN) for pain due to newly diagnosed, inoperable pancreatic cancer. Gastrointest Endosc 2009; 69: AB132.
74. CHANG KJ, NGUYEN PT, THOMPSON JA, KUROSAKI TT, CASEY LR, LEUNG EC, GRANGER GA. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000; 88: 1325-1335.
75. HECHT JR, BEDFORD R, ABBRUZZESE JL, LAHOTI S, REID TR, SOETIKNO RM, KIRN DH, FREEMAN SM. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003; 9: 555-561.
76. FARRELL JJ, SENZER N, HECHT JR, HANNA N, CHUNG T, NEMUNAITIS J, ROSEMURGY A, JAVLE M, REID T, POSNER M, MACKO J, CHANG K. Long-term data for endoscopic ultrasound (EUS) and percutanous (PTA) guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC). Gastrointest Endosc 2006; 63: AB93.
77. SUN S, XU H, XIN J, LIU J, GUO Q, LI S. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006; 38: 399-403.
78. JIN Z, DU Y, LI Z, JIANG Y, CHEN J, LIU Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy 2008; 40: 314-320.
79. VAN DAM J, VARADARAJULU S, JIN Z; EUS 2008 WORKING GROUP. EUS 2008 Working Group document: evaluation of EUS-guided implantation therapy (with video). Gastrointest Endosc 2009; 69(2 Suppl): S49-S53.
80. CHAN HH, NISHIOKA NS, MINO M, LAUWERS GY, PURICELLI WP, COLLIER KN, BRUGGE WR. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc 2004; 59: 95-99. (Pubitemid 38095520)
81. YUSUF TE, MATTHES K, BRUGGE WR. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc 2008; 67: 957-961.
82. GOLDBERG SN, MALLERY S, GAZELLE GS, BRUGGE WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999; 50: 392-401.
83. CARRARA S, ARCIDIACONO PG, ALBARELLO L, ADDIS A, ENDERLE MD, BOEMO C, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy 2008; 40: 321-326.